Matches 1 - 50 out of 180 1 2 3 4 >


Match Document Document Title
US20150050319 NATURAL SAPONIN-BASED SYNTHETIC IMMUNOADJUVANTS  
The present disclosure encompasses QS-21-based structurally-defined adjuvants to address the need for stronger, safer, and easier-to-access adjuvants. The new compositions can provide tools for...
US20100330176 Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity  
The invention relates to the use of ambroxol and the pharmacologically acceptable salts thereof for preparing a pharmaceutical composition for the treatment of painful conditions in the oral and...
US20110009351 SCREENING ASSAY TO IDENTIFY CORRECTORS OF PROTEIN TRAFFICKING DEFECTS  
The present invention relates to a novel assay or screen for identifying compounds with potential therapeutic value for the treatment of protein trafficking diseases such as Cystic Fibrosis (CF)...
US20120071431 Platycodin Radix Extracts, and Their Use in Treating Disease Conditions Associated with Angiogenesis  
Extracts of radix platycodin are used to inhibit angiogenesis, particularly angiogenesis that is associated with disease conditions other than obesity or cancer.
US20130338089 METHODS AND COMPOUNDS FOR MODULATING THE SECRETION OR EXPRESSION OF ADHESION PROTEINS OR ANGIOPOIETINS OF CELLS  
This invention provides methods, processes, compounds and compositions for modulating the gene expression or secretion of adhesion proteins, angiopoietins or their receptors to cure diseases, for...
US20130171283 SKIN CARE FORMULATION  
Disclosed is a composition, and method for its use, that includes any one of, any combination of, or all of Centella asiactica, Vitis vinifera seed, Magnolia bark, Camellia sinensis, and/or...
US20120100223 LIPID-CONTAINING COMPOSITIONS AND METHODS OF USE THEREOF  
Lipid compositions comprising nuts, seeds, oils, legumes, fruits, grains, and dairy useful in specified amounts as dietary supplements and diet plans designed around and including the...
US20140073592 Ginkgo Derived Compositions And Their Use To Prevent Fruit Infestation by Codling Moth  
Codling moth, Cydia pomonella, (L.), is a cosmopolitan pest of the apple, potentially causing damage to circa 80% of the fruit. Disclosed here are use of extract of Ginkgo biloba, or its synthetic...
US20110014204 Cancer Chemoprevention Strategy Based on Loss of Imprinting of IGF2  
The present invention relates to targets of loss of imprinting (LOI) affected IGF2 gene products in pre-malignant tissues, where methods of inhibiting those targets, including IGFR1, are disclosed...
US20110065662 Compounds, Compositions, and Methods for Protecting Brain Health in Neurodegenerative Disorders  
Aspects of the invention relate to compounds, extracts and compositions thereof, and methods of using of the same, to treat neurodegenerative disorders and/or improve brain health. In certain...
US20110230430 SAPONIN EXTRACT FROM SAPONARIA SPP. AND USES THEREOF  
A saponin extract from Saponaria vaccaria and its use for stimulating apoptosis in cancer cells and treating cancer is described. The saponin extract may be isolated from Saponaria vaccaria seed....
US20110104065 GENETIC ALTERATION ASSOCIATED WITH PRE-MALIGNANT CANCER  
Described herein are progenitor cancer cells and cell lines isolated from human breast ductal carcinoma in situ (DCIS) lesions and the uses of these cells or cell lines in drug design, drug...
US20100310487 ACTIVE INGREDIENT COMBINATION AND USE THEREOF  
An active ingredient combination which comprises a) glycerol monoalkyl ether, b) bispyridinium alkane, c) polyol and d) antioxidant. The combination is advantageously used for producing a...
US20100317606 NOVEL TRITERPENES FOR MODULATING GENE EXPRESSION AND CELL MEMBRANE, AND AS ANTIPROTOZOAL AGENTS  
This invention provides methods, processes, compounds and compositions for modulating the gene expression or secretion of adhesion proteins, angiopoietins or their receptors to cure diseases, for...
US20120071704 MITOCHONDRIAL LOCALIZATION OF MUC1  
The invention provides methods of identifying and making compounds that inhibit the interaction between MUC1 and either or both of HSP70 and HSP90. Also embraced by the invention are in vivo and...
US20080279933 FLURBIPROFEN AND MUSCLE RELAXANT COMBINATIONS  
This invention is a novel pharmaceutical composition comprising flurbiprofen or a pharmaceutically acceptable salt thereof in combination with an α-2 adrenergic receptor agonist or a...
US20120053142 COMPOSITIONS AND METHODS FOR MINIMIZING AND/OR REDUCING THE APPEARANCE OF DEFECTS AROUND EYES  
The invention relates to compositions comprising at least one xanthine compound, preferably further comprising at least one agent which acts on capillary circulation and/or at least one natural...
US20140080780 identification of compounds that disperse tdp-43 inclusions  
Herein, methods of modulating inclusion formation and stress granules in cells are described. The methods comprise contacting a cell with an inclusion inhibitor. Methods for screening for...
US20150017099 DIAGNOSIS AND TREATMENT FOR RESPIRATORY TRACT DISEASES  
The invention provides methods and compositions for the diagnosis, prognosis and treatment of respiratory tract diseases. Specifically, the invention provides diagnosis, prognosis and treatment of...
US20140154180 Pharmacophores for Amyloid Fibers Involved in Alzheimer's Disease  
This invention relates, e.g., to a method for designing or selecting on a computer a candidate small molecule amyloid binder or inhibitor, comprising: a) docking test compounds to the binding site...
US20090215708 Treatment of Sexual Dysfunction with Proton Pump Agonists  
Methods of treating a subject for sexual dysfunction are provided. Aspects of the methods include administering to the subject an effective amount of a proton pump agonist. Aspects of the...
US20150238510 STABLE INJECTABLE COMPOSITION CONTAINING DICLOFENAC AND THIOCOLCHICOSIDE  
The invention relates to a stable injectable aqueous solution containing diclofenac and thiocolchicoside, or pharmaceutically acceptable salts thereof, and the use thereof in the treatment of...
US20090291905 FUNGAL PHYTOTOXIN FUSICOCCIN FOR THE TREATMENT AND DIAGNOSIS OF COAGULATION-CORRELATED PATHOLOGIES  
The present invention concerns the use of tricyclic terpenes chosen from the group consisting of fusicoccin, ophyobolins or cotylenins for the therapy and diagnosis of coagulation-correlated...
US20130101632 NANOPARTICULATE FORMULATIONS OF MITHRAMYCIN OR MITHRAMYCIN ANALOGUES FOR TREATING CANCER  
Methods and formulations for improving therapeutic potential of mithramycin (MTM) or MTM analogues are disclosed. For example, in certain aspects, methods for preparing a composition containing...
US20150141358 REDUCED TOXICITY IN ALCOHOLIC BEVERAGES  
The present invention relates to reduced toxicity of functional alcoholic beverage composition comprising distilled alcohol, deionized water, 18β-Glycyrrhizin or 18α-Glycyrrhizin and a sugar...
US20100298251 WOUND-HEALING AGENT CONTAINING MOMORDICAE SEMEN EXTRACT  
The present invention relates to Momordicae semen extract having wound-healing efficiencies. In particular, the present invention relates to a wound-healing topical transdermal agent comprising an...
US20140323420 REDUCING TRANSMISSION OF SEXUALLY TRANSMITTED INFECTIONS  
Described herein are compositions and methods for treating or preventing a sexually transmitted infection in a subject
US20110171289 COMBINATIONS FOR THE TREATMENT OF DISEASES INVOLVING CELL PROLIFERATION, MIGRATION OR APOPTOSIS OF MYELOMA CELLS, OR ANGIOGENESIS  
The present invention relates to a pharmaceutical combination for the treatment of diseases which involves cell proliferation, migration or apoptosis of myeloma cells, or angiogenesis. The...
US20130345146 NEAR-INFRARED ELECTROMAGNETIC MODIFICATION OF CELLULAR STEADY-STATE MEMBRANE POTENTIALS  
Systems and methods are disclosed herein for applying near-infrared optical energies and dosimetries to alter the bioenergetic steady-state trans-membrane and mitochondrial potentials (ΔΨ-steady)...
US20130142730 COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER  
The present invention provides organic arsenicals. Many of these compounds have potent in vitro cytotoxic activity against numerous human tumor cell lines, both of solid and hematological origin,...
US20120028916 COSMETIC COMPOSITIONS COMPRISING ORIDONIN AND NEW COSMETIC USES  
The present invention related to cosmetic compositions comprising oridonin and new cosmetic uses. Oridonin is used for fighting the signs of cutaneous aging and for slimming. A composition...
US20090175938 Controlled Release Flurbiprofen and Muscle Relaxant Combinations  
This invention is a novel controlled release (CR) flurbiprofen and muscle relaxant combinations for oral administration with anti-inflammatory, analgesic, myorelaxant activity and methods of its...
US20070196517 Modified Saponin Molluscicide  
Saponins from plant materials are alkaline modified and used as molluscicides.
US20060116331 Glycosylceramide analogues  
Glycosylceramide analogues are disclosed in which the ceramide moiety and optionally the carbohydrate moiety are modified or replaced. These analogues are useful as immunomodulators, antitumor...
US20110229474 MONITORING AND INHIBITING HUMAN IMMUNODEFICIENCY VIRUS INFECTION BY MODULATING HMGB1 DEPENDENT TRIGGERING OF HIV-1 REPLICATION AND PERSISTENCE  
Compositions and methods for modulating human immunodeficiency virus (HIV) infection involving substances that inhibit the ability of high mobility box 1 (HMGB1) protein to interact with natural...
US20140308374 Formulations of Concentrated Prunes and Prebiotics as Laxatives and Dietary Supplements  
The present invention describes a formulation comprising a prune and/or plum concentrate, and one or more water-soluble, non-digestible, prebiotic oligosaccharides. Optionally, one or more low...
US20150231164 SIRTUIN GENE POTENTIATOR, AND PHARMACEUTICAL PRODUCT, COSMETIC PRODUCT, AND FOOD PRODUCT USING SAME  
Disclosed are a sirtuin gene potentiator, and a pharmaceutical product, a cosmetic product, and a food product using the same. The sirtuin gene potentiator of the present invention contains a...
US20070212329 Vaccine Compositions Comprising An Interleukin 18 And Saponin Adjuvant System  
This invention relates to a combination therapy that finds utility in the treatment or prophylaxis of infectious diseases, cancers, autoimmune diseases and related conditions. In particular, the...
US20070134194 Use of licochalcone A against rosacea  
The present invention relates to the use of licochalcone A for the treatment of rosacea.
US20130157967 Use Of A Phospholipid-Containing Composition For The Removal Of Subcutaneous Fat Accumulations By Subcutaneous Lipolysis  
The invention described herein relates to the use of an aqueous composition containing at least one phospholipid. at least one glycyrrhizic acid or salts of glycyrrhizic acid for the manufacture...
US20140155342 PATCH CONTAINING DICLOFENAC AND THIOCOLCHICOSIDE  
The present invention relates to a patch for the transdermal release of diclofenac or a pharmaceutically acceptable salt thereof, in particular diethylamine salt, and thiocolchicoside.
US20150209485 INTERVENTIONAL MEDICAL DEVICE AND MANUFACTURING METHOD THEREOF  
An interventional medical device and manufacturing method thereof. The interventional medical device comprises: a stent body (1); a surface of the stent body (1) being provided with a drug...
US20130018009 ANTI-OBESITY PRODUCT AND ITS METHOD OF PREPARATION  
The present invention relates to compositions comprising one or more anthraquinones for use in the treatment of obesity and related metabolic and liver disease. More particularly it relates to a...
US20130143831 TOPICAL PHARMACEUTICAL COMPOSITION COMPRISING FLURBIPROFEN  
The invention provides topical pharmaceutical compositions comprising flurbiprofen, or a pharmaceutically acceptable derivative thereof, in combination with a solubilising system which comprises...
US20130005666 REPORTER SYSTEM FOR HIGH THROUGHPUT SCREENING OF COMPOUNDS AND USES THEREOF  
The NF-E2-related factor 2 (Nrf2) is a key transcriptional regulator of antioxidant defense and detoxification. To directly monitor stabilization of Nrf2 we fused its Neh2 domain, responsible for...
US20140072663 Compositions and Methods for Treating Multi-Drug Resistant Malaria  
A method is provided for treating an individual for a malarial infection, in particular drug-resistant species of Plasmodium, including administering to the individual in need of such treatment a...
US20120263660 Hair Loss Treatment  
This invention relates to the use of cortisol blockers (glucocorticoid receptor [GR] antagonists) for the prevention or treatment of stress induced hair loss.
US20120165279 PHARMACEUTICAL COMPOSITION AND METHOD FOR PREVENTING OR TREATING HEPATITIS C  
A pharmaceutical composition for preventing or treating hepatitis C is provided, including oleanolic acid derivatives as an active ingredient and a pharmaceutically acceptable carrier. A method...
US20130150317 COMPOUNDS FOR THE TREATMENT OF RENAL CELL CARCINOMA  
A composition comprising mithramycin or a pharmaceutically acceptable salt or solvate thereof for use in the treatment of renal cell carcinoma. In particular, the composition is suitable for use...
US20110293691 MULTIMODAL ADHESION BARRIER  
Provided herein are multimodal barrier materials useful for preventing adhesions in a subject, which may include a collagen, a collagen deposition inhibitor and/or a chitosan.

Matches 1 - 50 out of 180 1 2 3 4 >